1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global COVID-19 Medicine Market Size Growth Rate by Type (2022-2028)
        1.2.2 Tablet
        1.2.3 Injection
    1.3 Market by Application
        1.3.1 Global COVID-19 Medicine Market Share by Application (2022-2028)
        1.3.2 Patients With Mild Symptoms
        1.3.3 Critically Ill
        1.3.4 Other
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global COVID-19 Medicine Market Size
    2.2 COVID-19 Medicine Market Size by Regions
        2.2.1 COVID-19 Medicine Growth Rate by Regions (2022-2028)
        2.2.2 COVID-19 Medicine Market Share by Regions (2022-2028)
    2.3 Industry Trends
        2.3.1 Market Top Trends
        2.3.2 Market Use Cases
3 Key Players
    3.1 COVID-19 Medicine Revenue by Players (2022 & 2028)
    3.2 COVID-19 Medicine Key Players Headquarters and Area Served
    3.3 Key Players COVID-19 Medicine Product/Solution/Service
    3.4 Date of Enter into COVID-19 Medicine Market
    3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown by Type and by Application
    4.1 Global COVID-19 Medicine Market Size by Type (2022-2028)
    4.2 Global COVID-19 Medicine Market Size by Application (2022-2028)
5 North America
    5.1 North America COVID-19 Medicine Market Forecast (2022-2028)
    5.2 COVID-19 Medicine Key Players in North America
    5.3 North America COVID-19 Medicine Market Size by Type
    5.4 North America COVID-19 Medicine Market Size by Application
6 Europe
    6.1 Europe COVID-19 Medicine Market Forecast (2022-2028)
    6.2 COVID-19 Medicine Key Players in Europe
    6.3 Europe COVID-19 Medicine Market Size by Type
    6.4 Europe COVID-19 Medicine Market Size by Application
7 Asia-Pacific
    7.1 Asia-Pacific COVID-19 Medicine Market Forecast (2022-2028)
    7.2 COVID-19 Medicine Key Players in Asia-Pacific
    7.3 Asia-Pacific COVID-19 Medicine Market Size by Type
    7.4 Asia-Pacific COVID-19 Medicine Market Size by Application
8 Rest of World
    8.1 Latin America
        8.1.1 Latin America COVID-19 Medicine Market Analysis
        8.1.2 Key Players in Latin America
    8.2 Middle East & Africa
        8.2.1 Middle East & Africa COVID-19 Medicine Market Analysis
        8.2.2 Key Players in Middle East & Africa
9 International Player Profiles
    9.1 Advanz Pharma
        9.1.1 Advanz Pharma Company Details
        9.1.2 Advanz Pharma Description and Business Overview
        9.1.3 Advanz Pharma COVID-19 Medicine Introduction
        9.1.4 Advanz Pharma Revenue in COVID-19 Medicine Business (2022 & 2028)
        9.1.5 Advanz Pharma Recent Development
    9.2 Kyung Poong
        9.2.1 Kyung Poong Company Details
        9.2.2 Kyung Poong Description and Business Overview
        9.2.3 Kyung Poong COVID-19 Medicine Introduction
        9.2.4 Kyung Poong Revenue in COVID-19 Medicine Business (2022 & 2028)
        9.2.5 Kyung Poong Recent Development
    9.3 Mylan
        9.3.1 Mylan Company Details
        9.3.2 Mylan Description and Business Overview
        9.3.3 Mylan COVID-19 Medicine Introduction
        9.3.4 Mylan Revenue in COVID-19 Medicine Business (2022 & 2028)
        9.3.5 Mylan Recent Development
    9.4 Novartis
        9.4.1 Novartis Company Details
        9.4.2 Novartis Description and Business Overview
        9.4.3 Novartis COVID-19 Medicine Introduction
        9.4.4 Novartis Revenue in COVID-19 Medicine Business (2022 & 2028)
        9.4.5 Novartis Recent Development
    9.5 Sanofi
        9.5.1 Sanofi Company Details
        9.5.2 Sanofi Description and Business Overview
        9.5.3 Sanofi COVID-19 Medicine Introduction
        9.5.4 Sanofi Revenue in COVID-19 Medicine Business (2022 & 2028)
        9.5.5 Sanofi Recent Development
    9.6 Apotex
        9.6.1 Apotex Company Details
        9.6.2 Apotex Description and Business Overview
        9.6.3 Apotex COVID-19 Medicine Introduction
        9.6.4 Apotex Revenue in COVID-19 Medicine Business (2022 & 2028)
        9.6.5 Apotex Recent Development
    9.7 Bayer
        9.7.1 Bayer Company Details
        9.7.2 Bayer Description and Business Overview
        9.7.3 Bayer COVID-19 Medicine Introduction
        9.7.4 Bayer Revenue in COVID-19 Medicine Business (2022 & 2028)
        9.7.5 Bayer Recent Development
    9.8 Guangzhou Baiyunshan Guanghua Pharmaceutical
        9.8.1 Guangzhou Baiyunshan Guanghua Pharmaceutical Company Details
        9.8.2 Guangzhou Baiyunshan Guanghua Pharmaceutical Description and Business Overview
        9.8.3 Guangzhou Baiyunshan Guanghua Pharmaceutical COVID-19 Medicine Introduction
        9.8.4 Guangzhou Baiyunshan Guanghua Pharmaceutical Revenue in COVID-19 Medicine Business (2022 & 2028)
        9.8.5 Guangzhou Baiyunshan Guanghua Pharmaceutical Recent Development
    9.9 Ipca Laboratories
        9.9.1 Ipca Laboratories Company Details
        9.9.2 Ipca Laboratories Description and Business Overview
        9.9.3 Ipca Laboratories COVID-19 Medicine Introduction
        9.9.4 Ipca Laboratories Revenue in COVID-19 Medicine Business (2022 & 2028)
        9.9.5 Ipca Laboratories Recent Development
    9.10 Sichuan Sunny Hope
        9.10.1 Sichuan Sunny Hope Company Details
        9.10.2 Sichuan Sunny Hope Description and Business Overview
        9.10.3 Sichuan Sunny Hope COVID-19 Medicine Introduction
        9.10.4 Sichuan Sunny Hope Revenue in COVID-19 Medicine Business (2022 & 2028)
        9.10.5 Sichuan Sunny Hope Recent Development
    9.11 Zydus Cadila
        9.11.1 Zydus Cadila Company Details
        9.11.2 Zydus Cadila Description and Business Overview
        9.11.3 Zydus Cadila COVID-19 Medicine Introduction
        9.11.4 Zydus Cadila Revenue in COVID-19 Medicine Business (2022 & 2028)
        9.11.5 Zydus Cadila Recent Development
    9.12 Teva
        9.12.1 Teva Company Details
        9.12.2 Teva Description and Business Overview
        9.12.3 Teva COVID-19 Medicine Introduction
        9.12.4 Teva Revenue in COVID-19 Medicine Business (2022 & 2028)
        9.12.5 Teva Recent Development
    9.13 Sun Pharma
        9.13.1 Sun Pharma Company Details
        9.13.2 Sun Pharma Description and Business Overview
        9.13.3 Sun Pharma COVID-19 Medicine Introduction
        9.13.4 Sun Pharma Revenue in COVID-19 Medicine Business (2022 & 2028)
        9.13.5 Sun Pharma Recent Development
    9.14 Rising Pharmaceutical
        9.14.1 Rising Pharmaceutical Company Details
        9.14.2 Rising Pharmaceutical Description and Business Overview
        9.14.3 Rising Pharmaceutical COVID-19 Medicine Introduction
        9.14.4 Rising Pharmaceutical Revenue in COVID-19 Medicine Business (2022 & 2028)
        9.14.5 Rising Pharmaceutical Recent Development
    9.15 KPC Group
        9.15.1 KPC Group Company Details
        9.15.2 KPC Group Description and Business Overview
        9.15.3 KPC Group COVID-19 Medicine Introduction
        9.15.4 KPC Group Revenue in COVID-19 Medicine Business (2022 & 2028)
        9.15.5 KPC Group Recent Development
    9.16 Bristol Laboratories
        9.16.1  Company Details
        9.16.2 Bristol Laboratories Description and Business Overview
        9.16.3 Bristol Laboratories COVID-19 Medicine Introduction
        9.16.4 Bristol Laboratories Revenue in COVID-19 Medicine Business (2022 & 2028)
        9.16.5 Bristol Laboratories Recent Development
    9.17 Shanghai Zhongxisanwei
        9.17.1 Shanghai Zhongxisanwei Company Details
        9.17.2 Shanghai Zhongxisanwei Description and Business Overview
        9.17.3 Shanghai Zhongxisanwei COVID-19 Medicine Introduction
        9.17.4 Shanghai Zhongxisanwei Revenue in COVID-19 Medicine Business (2022 & 2028)
        9.17.5 Shanghai Zhongxisanwei Recent Development
    9.18 Shanghai Pharma
        9.18.1 Shanghai Pharma Company Details
        9.18.2 Shanghai Pharma Description and Business Overview
        9.18.3 Shanghai Pharma COVID-19 Medicine Introduction
        9.18.4 Shanghai Pharma Revenue in COVID-19 Medicine Business (2022 & 2028)
        9.18.5 Shanghai Pharma Recent Development
10 Market Dynamics
    10.1 Industry Trends
    10.2 Market Drives
    10.3 Market Challenges
    10.4 Market Restraints
11 Key Findings in This Report
12 Appendix
    12.1 Research Methodology
        12.1.1 Methodology/Research Approach
        12.1.2 Data Source
    12.2 Disclaimer
    12.3 Author Details
                  
              

                

                 
List of Tables
    Table 1. Global COVID-19 Medicine Market Size Growth Rate by Type (2022-2028) (US$ Million)
    Table 2. Key Players of Tablet
    Table 3. Key Players of Injection
    Table 4. Global COVID-19 Medicine Market Size Growth by Application (2022-2028) (US$ Million)
    Table 5. Global COVID-19 Medicine Market Size by Regions (2022-2028) (US$ Million)
    Table 6. Global COVID-19 Medicine Market Share by Regions (2022-2028)
    Table 7. Market Top Trends
    Table 8. Market Use Cases
    Table 9. Global COVID-19 Medicine Revenue by Players (2022 & 2028) (US$ Million)
    Table 10. Global COVID-19 Medicine Market Share by Players (2022 &2028)
    Table 11. Key Players Headquarters and Area Served
    Table 12. Key Players COVID-19 Medicine Product/Solution/Service
    Table 13. Date of Enter into COVID-19 Medicine Market
    Table 14. Mergers & Acquisitions, Expansion Plans
    Table 15. Global COVID-19 Medicine Market Size by Type (2022-2028) (US$ Million)
    Table 16. Global COVID-19 Medicine Market Size Share by Type (2022-2028)
    Table 17. Global COVID-19 Medicine Market Size by Application (2022-2028) (US$ Million)
    Table 18. Global COVID-19 Medicine Market Size Share by Application (2022-2028)
    Table 19. North America Key Players COVID-19 Medicine Revenue (2022 & 2028) & (US$ Million)
    Table 20. North America Key Players COVID-19 Medicine Market Share (2022 & 2028)
    Table 21. North America COVID-19 Medicine Market Size by Type (2022-2028) (US$ Million)
    Table 22. North America COVID-19 Medicine Market Share by Type (2022-2028)
    Table 23. North America COVID-19 Medicine Market Size by Application (2022-2028) (US$ Million)
    Table 24. North America COVID-19 Medicine Market Share by Application (2022-2028)
    Table 25. Europe Key Players COVID-19 Medicine Revenue (2022 & 2028) & (US$ Million)
    Table 26. Europe Key Players COVID-19 Medicine Market Share (2022 & 2028)
    Table 27. Europe COVID-19 Medicine Market Size by Type (2022-2028) (US$ Million)
    Table 28. Europe COVID-19 Medicine Market Share by Type (2022-2028)
    Table 29. Europe COVID-19 Medicine Market Size by Application (2022-2028) (US$ Million)
    Table 30. Europe COVID-19 Medicine Market Share by Application (2022-2028)
    Table 31. Asia-Pacific Key Players COVID-19 Medicine Revenue (2022 & 2028) & (US$ Million)
    Table 32. Asia-Pacific Key Players COVID-19 Medicine Market Share (2022 & 2028)
    Table 33. Asia-Pacific COVID-19 Medicine Market Size by Type (2022-2028) (US$ Million)
    Table 34. Asia-Pacific COVID-19 Medicine Market Share by Type (2022-2028)
    Table 35. Asia-Pacific COVID-19 Medicine Market Size by Application (2022-2028) (US$ Million)
    Table 36. Asia-Pacific COVID-19 Medicine Market Share by Application (2022-2028)
    Table 37. Key Players in Latin America
    Table 38. Key Players in Middle East & Africa
    Table 39. Advanz Pharma Company Details
    Table 40. Advanz Pharma Description and Business Overview
    Table 41. Advanz Pharma COVID-19 Medicine Product
    Table 42. Advanz Pharma Revenue in COVID-19 Medicine Business 2022 & 2028
    Table 43. Advanz Pharma Recent Development
    Table 44. Kyung Poong Company Details
    Table 45. Kyung Poong Description and Business Overview
    Table 46. Kyung Poong COVID-19 Medicine Product
    Table 47. Kyung Poong Revenue in COVID-19 Medicine Business 2022 & 2028
    Table 48. Kyung Poong Recent Development
    Table 49. Mylan Company Details
    Table 50. Mylan Description and Business Overview
    Table 51. Mylan COVID-19 Medicine Product
    Table 52. Mylan Revenue in COVID-19 Medicine Business 2022 & 2028
    Table 53. Mylan Recent Development
    Table 54. Novartis Company Details
    Table 55. Novartis Description and Business Overview
    Table 56. Novartis COVID-19 Medicine Product
    Table 57. Novartis Revenue in COVID-19 Medicine Business 2022 & 2028
    Table 58. Novartis Recent Development
    Table 59. Sanofi Company Details
    Table 60. Sanofi Description and Business Overview
    Table 61. Sanofi COVID-19 Medicine Product
    Table 62. Sanofi Revenue in COVID-19 Medicine Business 2022 & 2028
    Table 63. Sanofi Recent Development
    Table 64. Apotex Company Details
    Table 65. Apotex Description and Business Overview
    Table 66. Apotex COVID-19 Medicine Product
    Table 67. Apotex Revenue in COVID-19 Medicine Business 2022 & 2028
    Table 68. Apotex Recent Development
    Table 69. Bayer Company Details
    Table 70. Bayer Description and Business Overview
    Table 71. Bayer COVID-19 Medicine Product
    Table 72. Bayer Revenue in COVID-19 Medicine Business 2022 & 2028
    Table 73. Bayer Recent Development
    Table 74. Guangzhou Baiyunshan Guanghua Pharmaceutical Company Details
    Table 75. Guangzhou Baiyunshan Guanghua Pharmaceutical Description and Business Overview
    Table 76. Guangzhou Baiyunshan Guanghua Pharmaceutical COVID-19 Medicine Product
    Table 77. Guangzhou Baiyunshan Guanghua Pharmaceutical Revenue in COVID-19 Medicine Business 2022 & 2028
    Table 78. Guangzhou Baiyunshan Guanghua Pharmaceutical Recent Development
    Table 79. Ipca Laboratories Company Details
    Table 80. Ipca Laboratories Description and Business Overview
    Table 81. Ipca Laboratories COVID-19 Medicine Product
    Table 82. Ipca Laboratories Revenue in COVID-19 Medicine Business 2022 & 2028
    Table 83. Ipca Laboratories Recent Development
    Table 84. Sichuan Sunny Hope Company Details
    Table 85. Sichuan Sunny Hope Description and Business Overview
    Table 86. Sichuan Sunny Hope COVID-19 Medicine Product
    Table 87. Sichuan Sunny Hope Revenue in COVID-19 Medicine Business 2022 & 2028
    Table 88. Sichuan Sunny Hope Recent Development
    Table 89. Zydus Cadila Company Details
    Table 90. Zydus Cadila Description and Business Overview
    Table 91. Zydus Cadila COVID-19 Medicine Product
    Table 92. Zydus Cadila Revenue in COVID-19 Medicine Business 2022 & 2028
    Table 93. Zydus Cadila Recent Development
    Table 94. Teva Company Details
    Table 95. Teva Description and Business Overview
    Table 96. Teva COVID-19 Medicine Product
    Table 97. Teva Revenue in COVID-19 Medicine Business 2022 & 2028
    Table 98. Teva Recent Development
    Table 99. Sun Pharma Company Details
    Table 100. Sun Pharma Description and Business Overview
    Table 101. Sun Pharma COVID-19 Medicine Product
    Table 102. Sun Pharma Revenue in COVID-19 Medicine Business 2022 & 2028
    Table 103. Sun Pharma Recent Development
    Table 104. Rising Pharmaceutical Company Details
    Table 105. Rising Pharmaceutical Description and Business Overview
    Table 106. Rising Pharmaceutical COVID-19 Medicine Product
    Table 107. Rising Pharmaceutical Revenue in COVID-19 Medicine Business 2022 & 2028
    Table 108. Rising Pharmaceutical Recent Development
    Table 109. KPC Group Company Details
    Table 110. KPC Group Description and Business Overview
    Table 111. KPC Group COVID-19 Medicine Product
    Table 112. KPC Group Revenue in COVID-19 Medicine Business 2022 & 2028
    Table 113. KPC Group Recent Development
    Table 114. Bristol Laboratories Company Details
    Table 115. Bristol Laboratories Description and Business Overview
    Table 116. Bristol Laboratories COVID-19 Medicine Product
    Table 117. Bristol Laboratories Revenue in COVID-19 Medicine Business 2022 & 2028
    Table 118. Bristol Laboratories Recent Development
    Table 119. Shanghai Zhongxisanwei Company Details
    Table 120. Shanghai Zhongxisanwei Description and Business Overview
    Table 121. Shanghai Zhongxisanwei COVID-19 Medicine Product
    Table 122. Shanghai Zhongxisanwei Revenue in COVID-19 Medicine Business 2022 & 2028
    Table 123. Shanghai Zhongxisanwei Recent Development
    Table 124. Shanghai Pharma Company Details
    Table 125. Shanghai Pharma Description and Business Overview
    Table 126. Shanghai Pharma COVID-19 Medicine Product
    Table 127. Shanghai Pharma Revenue in COVID-19 Medicine Business 2022 & 2028
    Table 128. Shanghai Pharma Recent Development
    Table 129. COVID-19 Medicine Market Trends
    Table 130. COVID-19 Medicine Market Drivers
    Table 131. COVID-19 Medicine Market Challenges
    Table 132. COVID-19 Medicine Market Restraints
    Table 133. Research Programs/Design for This Report
    Table 134. Key Data Information from Secondary Sources
    Table 135. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global COVID-19 Medicine Market Share by Type in 2022 & 2028
    Figure 2. Tablet Features
    Figure 3. Injection Features
    Figure 4. Global COVID-19 Medicine Market Share by Application in 2022 & 2028
    Figure 5. Patients With Mild Symptoms Case Studies
    Figure 6. Critically Ill Case Studies
    Figure 7. Other Case Studies
    Figure 8. COVID-19 Medicine Report Years Considered
    Figure 9. Global COVID-19 Medicine Market Size and Growth Rate (2022-2028) (US$ Million)
    Figure 10. Global COVID-19 Medicine Market Share by Regions (2022-2028)
    Figure 11. Global COVID-19 Medicine Market Share by Players in 2021
    Figure 12. Global COVID-19 Medicine Market Size Market Share by Type (2022-2028)
    Figure 13. Global COVID-19 Medicine Market Size Market Share by Application (2022-2028)
    Figure 14. Global COVID-19 Medicine Revenue Market Share by Application in 2021
    Figure 15. North America COVID-19 Medicine Market Size 2022-2028 (US$ Million)
    Figure 16. Europe COVID-19 Medicine Market Size 2022-2028 (US$ Million)
    Figure 17. Asia-Pacific COVID-19 Medicine Market Size 2022-2028 (US$ Million)
    Figure 18. COVID-19 Medicine Market Size in Latin America (2022-2028) (US$ Million)
    Figure 19. COVID-19 Medicine Market Size in Middle East & Africa (2022-2028) (US$ Million)
    Figure 20. Bottom-up and Top-down Approaches for This Report
    Figure 21. Data Triangulation
    Figure 22. Key Executives Interviewed